Clinical Trials Insight: 700027314
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2008
At a glance
- Drugs Zileuton (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Nasal polyps
- Focus Adverse reactions
- Sponsors Critical Therapeutics
- 09 Apr 2008 Interim results have been reported by Clinical Therapeutics.
- 09 Apr 2008 Status changed from initiated to completed as reported by Critical Therapeutics.
- 03 Oct 2007 New trial record.